Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 19, 2010
Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanomaKatharina C Kähler, Axel HauschildJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 16, 2008
Current recommendations for prevention and therapy of extravasation reactions in dermato-oncologyKatharina C Kähler, Dieter Mustroph, Axel HauschildJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 11, 2013
Palliative treatment of skin metastases in dermato-oncologyKatharina C Kähler, Friederike Egberts, Ralf GutzmerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Management of immune-related adverse events and kinetics of response with ipilimumabJeffrey S Weber, Katharina C Kähler, Axel HauschildJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2008
Interdisciplinary management recommendations for toxicity associated with interferon-alfa therapyAxel Hauschild, Katharina C Kähler, Martin Schäfer, et al.Cancer Metastasis Reviews|June 14, 2006
Individualized therapy of disseminated cancer using malignant melanoma as a modelAxel Hauschild, Friederike Egberts, Paul Russo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 30, 2016
Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune DiseaseLara V Maul, Michael Weichenthal, Katharina C Kähler, et al.Journal of Cancer Research and Clinical Oncology|October 10, 2024
Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center KielCarolin Grote, Ann-Sophie Bohne, Christine Blome, et al.Journal of Cancer Research and Clinical Oncology|December 3, 2024
Preferences of melanoma patients to accept adjuvant therapy and toxicity - a qualitative substudy of the GerMelaTox-A projectToni Maria Janke, Laura Moysig, Christine Blome, et al.Journal of Patient-Reported Outcomes|August 28, 2021
Feasibility of assessing utilities with a single-item standard gamble questionnaire in patients with melanomaChristine Blome, Katharina C Kähler, Tobias Wagner, et al.Pageof 7